Nora Mühlegger

681 total citations
11 papers, 372 citations indexed

About

Nora Mühlegger is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nora Mühlegger has authored 11 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nora Mühlegger's work include Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Sarcoma Diagnosis and Treatment (2 papers). Nora Mühlegger is often cited by papers focused on Acute Myeloid Leukemia Research (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Sarcoma Diagnosis and Treatment (2 papers). Nora Mühlegger collaborates with scholars based in Austria, Germany and United States. Nora Mühlegger's co-authors include Michael Dworzak, Georg Mann, Helmut Gadner, Ulrike Pötschger, Dieter Printz, Gertraud Fröschl, G. Fritsch, Andishe Attarbaschi, Oskar A. Haas and M. Trebo and has published in prestigious journals such as Nature Communications, Blood and Leukemia.

In The Last Decade

Nora Mühlegger

11 papers receiving 365 citations

Peers

Nora Mühlegger
Arian van der Veer Netherlands
Alan W. Lankester United Kingdom
C. Knechtli United Kingdom
Sharon Bergeron United States
Ching‐Hon Pui United States
A Chauvenet United States
Arian van der Veer Netherlands
Nora Mühlegger
Citations per year, relative to Nora Mühlegger Nora Mühlegger (= 1×) peers Arian van der Veer

Countries citing papers authored by Nora Mühlegger

Since Specialization
Citations

This map shows the geographic impact of Nora Mühlegger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Mühlegger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Mühlegger more than expected).

Fields of papers citing papers by Nora Mühlegger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Mühlegger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Mühlegger. The network helps show where Nora Mühlegger may publish in the future.

Co-authorship network of co-authors of Nora Mühlegger

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Mühlegger. A scholar is included among the top collaborators of Nora Mühlegger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Mühlegger. Nora Mühlegger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Rasche, Mareike, Martina Pigazzi, Claudia Tregnago, et al.. (2025). Prognostic Value of Molecular Genetic Measurable Residual Disease ( MRD ) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10. European Journal Of Haematology. 115(5). 493–504. 1 indexed citations
2.
Kanter, Jurrian K. de, Mark Verheul, Markus J. van Roosmalen, et al.. (2024). Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms. Nature Communications. 15(1). 6025–6025. 8 indexed citations
3.
Maurer‐Granofszky, Margarita, Stefan Köhrer, Susanna Fischer, et al.. (2023). Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard-risk acute myeloid leukemia. Haematologica. 109(3). 740–750. 3 indexed citations
4.
Rasche, Mareike, Martin Zimmermann, Jean‐Pierre Bourquin, et al.. (2021). Second Relapse of Pediatric Patients with Acute Myeloid Leukemia: A Report on Current Treatment Strategies and Outcome of the AML-BFM Study Group. Cancers. 13(4). 789–789. 15 indexed citations
5.
Schumich, Angela, Michaela Prchal‐Murphy, Margarita Maurer‐Granofszky, et al.. (2019). Phospho‐Profiling Linking Biology and Clinics in Pediatric Acute Myeloid Leukemia. HemaSphere. 4(1). e312–e312. 7 indexed citations
6.
Boztug, Heidrun, Nora Mühlegger, Ulrike Pötschger, et al.. (2016). Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia. Annals of Hematology. 96(1). 99–106. 16 indexed citations
7.
Boztug, Heidrun, Nora Mühlegger, Evgenia Glogova, et al.. (2014). Development of treatment and clinical results in childhood AML in Austria (1993–2013). memo - Magazine of European Medical Oncology. 7(1). 63–74. 4 indexed citations
8.
Boztug, Heidrun, Angela Schumich, Ulrike Pötschger, et al.. (2013). Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome. Cytometry Part B Clinical Cytometry. 84(6). 370–378. 12 indexed citations
9.
Attarbaschi, Andishe, Georg Mann, Margit König, et al.. (2004). Incidence and relevance of secondary chromosome abnormalities in childhood TEL/AML1+ acute lymphoblastic leukemia: an interphase FISH analysis. Leukemia. 18(10). 1611–1616. 58 indexed citations
10.
Attarbaschi, Andishe, Georg Mann, Michael Dworzak, et al.. (2002). The role of surgery in the treatment of pediatric B-cell non-Hodgkin's lymphoma. Journal of Pediatric Surgery. 37(10). 1470–1475. 17 indexed citations
11.
Dworzak, Michael, Gertraud Fröschl, Dieter Printz, et al.. (2002). Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood. 99(6). 1952–1958. 231 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026